Transparency Provisions In EU Clinical Trial Portal To Be Reviewed In 2023
Public Consultation Expected In Q1 Next Year, Says EMA
The European Medicines Agency’s management board believes it is time to review the disclosure rules under the EU Clinical Trial Regulation that were agreed almost seven years ago.
